Document Detail

Application of a frequency definition of ventricular proarrhythmia.
MedLine Citation:
PMID:  3812259     Owner:  NLM     Status:  MEDLINE    
To differentiate spontaneous variability from proarrhythmia in patients with benign or potentially lethal ventricular arrhythmias, 495 patients with 2 or more Holter tracings during placebo therapy were evaluated. The Holter session with the highest frequency of ventricular premature complexes (VPCs) and ventricular tachycardia was compared with the first placebo recording. Patients were segregated by their baseline frequency of VPCs. The percent of patients taking placebo in this trial who had the same increase in VPC frequency as has been ascribed to those with proarrhythmia varied from 0 of 470 patients with a baseline frequency of ventricular arrhythmia of 10 to 50 VPCs/hour, 3 of 44 (7%) with 51 to 100 VPCs/hour, 1 of 139 (0.7%) with 101 to 300 VPCs/hour and 1 of 265 (0.04%) with more than 300 VPCs/hour. Overall, 5 of 496 (1%) patients would have been classified as having proarrhythmia using the algorithm although only placebo was given. A 10-fold or greater increase in ventricular tachycardia beats in patients taking placebo occurred in 9 of 274 patients (3%). Thus, a simple algorithm to define proarrhythmia in patients with mixed cardiac disease and chronic ventricular arrhythmias can be defined and differentiated from spontaneous variability. This arbitrary algorithm defines proarrhythmia as an increase of more than 3 times when baseline VPC frequency is more than 100 VPCs/hour and more than 10 times when that frequency is less than 100 VPCs/hour with a false-positive rate of only 1%.
J Morganroth; M Borland; G Chao
Related Documents :
9972969 - A pilot study: use of fludarabine for refractory dermatomyositis and polymyositis, and ...
8112919 - Analysis of high frequency qrs potentials observed during acute myocardial infarction.
17587719 - A prospective study on the risk-stratification for patients with non-sustained ventricu...
1549219 - Hypotension-induced vasopressin release distinguishes between pure autonomic failure an...
10725289 - Linear ablation lesions for control of unmappable ventricular tachycardia in patients w...
16171749 - Potential proarrhythmic effect of biventricular pacing: fact or myth?
25136879 - Cystatin c and risk of mortality among patients undergoing percutaneous coronary interv...
19457569 - Analysis of gd2/gm2 synthase mrna as a biomarker for small cell lung cancer.
18692289 - Resuscitation great. karel wenckebach: the story behind the block.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The American journal of cardiology     Volume:  59     ISSN:  0002-9149     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  1987 Jan 
Date Detail:
Created Date:  1987-02-25     Completed Date:  1987-02-25     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  97-9     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Arrhythmias, Cardiac / physiopathology*
Heart Ventricles
Monitoring, Physiologic
Retrospective Studies
Reg. No./Substance:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Chronotropic effect of hydralazine and its mechanism of symptomatic sinus bradycardia.
Next Document:  Role of calcium ion in maintenance of vascular smooth muscle tone.